BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2008
View Archived Issues
New agents for treating HIV infection reported in recent patent literature
Read More
HIF prolyl hydroxylase inhibitors for anemia prepared and tested at GSK
Read More
Prevention of acute, chronic rejection of solid tissue allografts with regulatory T cells
Read More
Abbott presents fourth quarter 2007 results
Read More
Recent patents disclose novel neuropsychiatric agents
Read More
Asenapine demonstrates long-term efficacy in bipolar disorder
Read More
Generex receives Ukrainian approval for phase III clinical trial of Generex Oral-lyn
Read More
Phase II dose of E-7974 in 21-day schedule determined in solid tumor patients
Read More
No objective responses seen with tremelimumab in gastric, esophageal adenocarcinoma
Read More
Abbott and Eisai announce changes in the sales scheme for adalimumab in Japan
Read More
Arius completes pre-IND meeting with FDA for lead anticancer antibody
Read More
Arno Therapeutics completes license agreements for novel targeted cancer compounds
Read More
Nabilone improves pain, quality of life in fibromyalgia patients
Read More
Calibrant collaborates with Cleveland Clinic on brain cancer drug discovery
Read More
Derma enters phase II development for wound-healing product
Read More
FDA accepts sNDA for Fentora for management of breakthrough pain
Read More
Medivation plans pivotal confirmatory phase III Dimebon trial in AD
Read More
N30 Pharma initiates human studies with N30-201
Read More
Oncothyreon highlights corporate and clinical objectives for 2008
Read More
FDA accepts AZX-100 IND application in dermal/hypertrophic scarring
Read More
Acrux reports results for phase I fentanyl trial using metered-dose transdermal spray
Read More
FDA approves Emend for Injection as part of treatment for CINV
Read More
Neose discontinues NE-180 program
Read More
FDA approves IND for clinical phase II trial with uPA inhibitor WX-671
Read More
Serenex collaborates with NCI for small-molecule Hsp90 inhibitors in lung cancer
Read More
Peregrine opens enrollment in phase II bavituximab trial in advanced breast cancer
Read More
Acorda Therapeutics announces successful QT study of Fampridine-SR
Read More